Filing Details
- Accession Number:
- 0001209191-22-010395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-16 20:08:34
- Reporting Period:
- 2022-02-14
- Accepted Time:
- 2022-02-16 20:08:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1306119 | T Kevin Conroy | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-14 | 94,425 | $9.07 | 765,212 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-14 | 96,758 | $10.82 | 861,970 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-14 | 31,133 | $78.33 | 893,103 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-15 | 14,409 | $79.55 | 878,694 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-02-14 | 94,425 | $0.00 | 94,425 | $9.07 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-02-14 | 96,758 | $0.00 | 96,758 | $10.82 |
| Common Stock | Restricted Stock Units | Disposition | 2022-02-14 | 31,133 | $0.00 | 31,133 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-27 | No | 4 | M | Direct | |
| 0 | 2023-02-22 | No | 4 | M | Direct | |
| 62,265 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 26,565 | Indirect | Held in 401(k) Plan |
| Common Stock | 21,730 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 21,730 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 21,729 | Indirect | Held in Grantor Retained Annuity Trust |
Footnotes
- Represents shares of Common Stock acquired upon the exercise of options in an exercise-and-hold transaction.
- Represents shares of common stock received upon vesting of a restricted stock unit award.
- Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 14, 2022.
- In addition to the shares of Common Stock reported on this Form 4, which total 970,448 shares, Mr. Conroy also holds, in the aggregate, an additional 985,601 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- These options vested in full on February 27, 2016.
- These options vested in full on February 22, 2017.
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- Represents a restricted stock unit award that partially vested on February 14, 2022. The restricted stock units vest in four equal annual installments beginning on February 14, 2021.
Billionaire Hedge Funds
